Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Cancer Cell International

Figure 1

From: Anti-tumor effect of ribavirin in combination with interferon-α on renal cell carcinoma cell lines in vitro

Figure 1

The effect of IFN-α and ribavirin alone and combined IFN-α and ribavirin treatment on the proliferation of the murine and human RCC cells. (A) Suppression of proliferation induced by IFN-α alone or in combination with ribavirin. (B) Suppression of proliferation induced by ribavirin alone or in combination with IFN-α. C1: combination of 500 IU/ml of IFN-α and 500 μM ribavirin. C2: 1000 IU/ml of IFN-α and 1000 μM ribavirin. The suppression was significant in the range of 20–1000 IU/ml of IFN-α or 100–1000 μM ribavirin. (*indicates a significant difference in comparison with controls).

Back to article page